Your browser doesn't support javascript.
loading
The ENIGMA-Epilepsy working group: Mapping disease from large data sets.
Sisodiya, Sanjay M; Whelan, Christopher D; Hatton, Sean N; Huynh, Khoa; Altmann, Andre; Ryten, Mina; Vezzani, Annamaria; Caligiuri, Maria Eugenia; Labate, Angelo; Gambardella, Antonio; Ives-Deliperi, Victoria; Meletti, Stefano; Munsell, Brent C; Bonilha, Leonardo; Tondelli, Manuela; Rebsamen, Michael; Rummel, Christian; Vaudano, Anna Elisabetta; Wiest, Roland; Balachandra, Akshara R; Bargalló, Núria; Bartolini, Emanuele; Bernasconi, Andrea; Bernasconi, Neda; Bernhardt, Boris; Caldairou, Benoit; Carr, Sarah J A; Cavalleri, Gianpiero L; Cendes, Fernando; Concha, Luis; Desmond, Patricia M; Domin, Martin; Duncan, John S; Focke, Niels K; Guerrini, Renzo; Hamandi, Khalid; Jackson, Graeme D; Jahanshad, Neda; Kälviäinen, Reetta; Keller, Simon S; Kochunov, Peter; Kowalczyk, Magdalena A; Kreilkamp, Barbara A K; Kwan, Patrick; Lariviere, Sara; Lenge, Matteo; Lopez, Seymour M; Martin, Pascal; Mascalchi, Mario; Moreira, José C V.
Afiliação
  • Sisodiya SM; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
  • Whelan CD; Chalfont Centre for Epilepsy, Bucks, UK.
  • Hatton SN; Department of Molecular and Cellular Therapeutics, The Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Huynh K; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, California, USA.
  • Altmann A; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, California, USA.
  • Ryten M; Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Vezzani A; UCL Queen Square Institute of Neurology, London, UK.
  • Caligiuri ME; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Labate A; Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Gambardella A; Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Ives-Deliperi V; Institute of Neurology, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Meletti S; Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Munsell BC; Institute of Neurology, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Bonilha L; Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Tondelli M; Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Rebsamen M; Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.
  • Rummel C; Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Vaudano AE; Department of Computer Science, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Wiest R; Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Balachandra AR; Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.
  • Bargalló N; Support Center for Advanced Neuroimaging, University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bartolini E; Support Center for Advanced Neuroimaging, University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bernasconi A; Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Bernasconi N; Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy.
  • Bernhardt B; Support Center for Advanced Neuroimaging, University Institute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Caldairou B; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, California, USA.
  • Carr SJA; Boston University School of Medicine, Boston, Massachusetts, USA.
  • Cavalleri GL; Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Cendes F; Radiology Department of Center of Image Diagnosis, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Concha L; Neurology Unit, USL Centro Toscana, Nuovo Ospedale Santo Stefano, Prato, Italy.
  • Desmond PM; Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
  • Domin M; Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
  • Duncan JS; McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
  • Focke NK; Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada.
  • Guerrini R; Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
  • Hamandi K; School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Jackson GD; FutureNeuro SFI Research Centre, Dublin, Ireland.
  • Jahanshad N; Department of Neurology and Neuroimaging Laboratory, University of Campinas - UNICAMP, Campinas, São Paulo, Brazil.
  • Kälviäinen R; Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico.
  • Keller SS; Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  • Kochunov P; Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Kowalczyk MA; Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
  • Kreilkamp BAK; Chalfont Centre for Epilepsy, Bucks, UK.
  • Kwan P; University Medicine Göttingen, Clinical Neurophysiology, Göttingen, Germany.
  • Lariviere S; Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Florence, Italy.
  • Lenge M; The Wales Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff, UK.
  • Lopez SM; Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, UK.
  • Martin P; Department of Neurology, Austin Health, Heidelberg, Victoria, Australia.
  • Mascalchi M; Florey Department of Neuroscience and Mental Health, University of Melbourne, Victoria, Australia.
  • Moreira JCV; Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, Marina del Rey, California, USA.
Hum Brain Mapp ; 2020 May 29.
Article em En | MEDLINE | ID: mdl-32468614
Epilepsy is a common and serious neurological disorder, with many different constituent conditions characterized by their electro clinical, imaging, and genetic features. MRI has been fundamental in advancing our understanding of brain processes in the epilepsies. Smaller-scale studies have identified many interesting imaging phenomena, with implications both for understanding pathophysiology and improving clinical care. Through the infrastructure and concepts now well-established by the ENIGMA Consortium, ENIGMA-Epilepsy was established to strengthen epilepsy neuroscience by greatly increasing sample sizes, leveraging ideas and methods established in other ENIGMA projects, and generating a body of collaborating scientists and clinicians to drive forward robust research. Here we review published, current, and future projects, that include structural MRI, diffusion tensor imaging (DTI), and resting state functional MRI (rsfMRI), and that employ advanced methods including structural covariance, and event-based modeling analysis. We explore age of onset- and duration-related features, as well as phenomena-specific work focusing on particular epilepsy syndromes or phenotypes, multimodal analyses focused on understanding the biology of disease progression, and deep learning approaches. We encourage groups who may be interested in participating to make contact to further grow and develop ENIGMA-Epilepsy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article